Biocryst Pharmaceuticals (BO1.F) Q1 2025 Earnings

24FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.19
-0.14
-0.09
-0.04

Details

Expected EPS
-0.04396312
Actual EPS
-0.12424360000000001
Surprise EPS
-0.08
Surprise Percent
+182.61%

Description

Biocryst Pharmaceuticals (BO1.F) has reported earnings of -0.12424360000000001 per share for Q1 2025.

0 Comments

Share your thoughts